A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2004
12/09/2004	US20040247582 Feed additive and/or drinking water additive for domestic animals
12/09/2004	US20040247581 Bacterial strains that adhere to intestinal gut (capability to adhere to the cell lines Caco-2 or Hep-2) and lowering the concentration of pathogenic peptides (measured as peptidase activity), used to treat behavioral or psychiatric disorders, such as autism, ADHD, mood disorders, and schizophrenia
12/09/2004	US20040247580 Cultivating a lactic acid bacteria in an aqueous protein solution (e.g., skim milk or soybean protein) containing a proteolytic enzyme; concentrating the solution to coat the culture with the protein; adding a polysaccharide such as xanthan gum, cellulose, or levan; homogenizing; and lyophilizing
12/09/2004	US20040247579 Mixed chimerism and tolerance
12/09/2004	US20040247575 Especially cells containing an exogenous nucleic acid encoding VEGF, fibroblast growth factor-4, a natiuretic peptide, prostacyclin synthase, nitric oxide synthase, angiostatin, endostatin, erythropoietin, granulocyte/macrophage colony stimulating factor, an integrin, or an interleukin
12/09/2004	US20040247574 Improving stem cell homing to bone marrow by contacting them for a period insufficient for cell division to occur with a CD26 peptidase inhibitor before administering them to a patent in need
12/09/2004	US20040247573 Living stromal tissue including mesenchymal cells of hair follicle (especially scalp or beard follicle) cultured in a three-dimensional framework and connective tissue proteins secreted from the cells; and a transitional covering connected to the stromal tissue.
12/09/2004	US20040247571 Neural cells expressing tyrosine hydroxylase
12/09/2004	US20040247569 Reduction in bacterial colonization by administering bacteriophage compositions
12/09/2004	US20040247567 Transfecting cells of the free flap ex vivo by perfusing with a suspension of a vector that is a nucleic acid encoding the product of interest under the control of a promoter; and reattaching the free flap to the native circulation using microvascular surgical techniques.
12/09/2004	US20040247564 Treating a tissue disorder involving a loss and/or apoptosis of cells by administering an agent that induces phosphorylation and/or activation of protein kinase B to cause proliferation; particularly administering a human stromal-derived factor-1 and a G-CSF to cause proliferation of cardiomyocytes
12/09/2004	US20040247563 Method of enhancing lymphocyte-mediated immune responses
12/09/2004	DE10322656A1 Pharmazeutischer Wirkstoff Active Pharmaceutical Ingredient
12/09/2004	CA2523977A1 New product
12/09/2004	CA2523774A1 Deer antler extract for promoting angiogenesis
12/08/2004	EP1484064A1 Therapeutical composition containing dentritic cells and use thereof
12/08/2004	EP1484063A2 Method for inhibiting rejection of transplanted tissue
12/08/2004	EP1483978A1 Biological process for the production of a food product comprising heme-iron and food product obtained with said process
12/08/2004	EP1483588A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
12/08/2004	EP1483575A2 Methods for isolating ligands e.g. t cell epitopes
12/08/2004	EP1483385A2 Compositions and methods for generating an immune response
12/08/2004	EP1483383A2 Methods anc compositions for in vivo clearance of pathogens
12/08/2004	EP1483375A1 A method for producing recombinant viruses using site-specific recombination
12/08/2004	EP1483372A2 Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions
12/08/2004	EP1483366A1 Antimicrobial composition
12/08/2004	EP1483288A2 Hbm variants that modulate bone mass and lipid levels
12/08/2004	EP1483281A1 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
12/08/2004	EP1483023A1 Compositions and methods for treatment of body weight conditions with milk minerals and casein fractions
12/08/2004	EP1482983A2 Non-myeloablative tolerogenic treatment with tyrphostins
12/08/2004	EP1482959A1 Compositions and methods for treatment of skin disorders
12/08/2004	EP1482958A1 Method for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections with bovine erythrocyte preparations
12/08/2004	EP1482916A2 Schwann cell and phosphodiesterase inhibitors based therapy
12/08/2004	EP1482811A1 Probiotic delivery system
12/08/2004	EP1482788A2 Compositions comprising reproductive cell media and methods for using such compositions
12/08/2004	EP1482787A2 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
12/08/2004	EP1444345A4 Conversion of liver stem and progenitor cells to pancreatic functional cells
12/08/2004	EP1390754A4 Method and composition for skin grafts
12/08/2004	EP1150694B1 Cell composition containing macrophages, presenting anti-infectious and hematopoietic properties, and a process for preparing the same
12/08/2004	EP1143797A4 Methods for reducing adverse side effects associated with cellular transplantation
12/08/2004	CN1553963A Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
12/08/2004	CN1553958A Photochemical internalization for delivery of molecules into the cytosol
12/08/2004	CN1553952A Materials and methods to promote repair of nerve tissue
12/08/2004	CN1553951A Human cord blood derived unrestricted somatic stem cells (USSC)
12/08/2004	CN1553817A Method for improving oxygen transport by stored red blood cells
12/08/2004	CN1553806A Use of SAPR-1 for the treatment and/or prevention of scleroderma
12/08/2004	CN1553805A Nutritional compositions for controlling blood glucose level
12/08/2004	CN1553798A Modifying the fatty acid composition of cell membranes of organs and tissues
12/08/2004	CN1553793A Hair follicle neogenesis by injection of follicle progenitor cells
12/08/2004	CN1552856A DNA encoding a plasminogen-activating protein
12/08/2004	CN1552733A Preparation of myocardium peptide
12/08/2004	CN1552439A Myocardium peptide and its use
12/08/2004	CN1552417A Extracts and use of Leimo
12/08/2004	CN1552349A Method and use for Chinese medicine and natural medicine compound active screening
12/08/2004	CN1179048C Modified MSP-1 nucleic acid sequences and method for increasing mRN-A level and protein expression in cell system
12/08/2004	CN1179047C Method for introducing substances into cells and use of said method
12/08/2004	CN1178950C Corpuscles of stannius protein and stanniocalcin
12/08/2004	CN1178697C Infectious bursits vaccine
12/08/2004	CN1178691C Medicine for clinical hemostasis and preparing method thereof
12/08/2004	CN1178683C Cerebral hemorrhage treating traditional Chinese medicine
12/08/2004	CN1178682C Angiocardiopathy treating traditional Chinese medicine
12/08/2004	CN1178681C Notoginseng and pangolin scales tinea curing pill
12/08/2004	CN1178680C Medicine of treating dermatosis for external use
12/08/2004	CN1178679C Medicine for curing asthma, chronic acid acute bronchitis and pulmonary emphysema
12/08/2004	CN1178675C Toxin-dischargin liver-fortifying medicine
12/08/2004	CN1178674C Bacteriostatic compositions for salmonellae
12/08/2004	CN1178673C Medicine for treatment of venereal disease
12/08/2004	CN1178672C Process for preparing polypeptide-nucleic acid nutritive liquid of sheep placenta
12/08/2004	CN1178671C Egg anti-inflammatory composition and isolation method and use
12/08/2004	CN1178670C Process for prodn. of biological prepn. for antisenesence
12/08/2004	CN1178592C Drinks and foods capable of eliminating helicobacter pylori
12/07/2004	US6828431 Compositions and methods for the therapy and diagnosis of breast cancer
12/07/2004	US6828340 Especially for cancer which has developed a multidrug-resistant phenotype.
12/07/2004	US6828323 Isoalloxazine derivatives to neutralize biological contaminants
12/07/2004	US6828306 Charged lipid compositions and methods for their use
12/07/2004	US6828150 Antigen presenting system and methods for activation of T-cells
12/07/2004	US6828148 Miniribozymes active at low magnesium ion concentrations
12/07/2004	US6828147 Method of modifying cytotoxic cells and uses thereof
12/07/2004	US6827940 Forming nontoxic, stable, water soluble antitumor powders; heat and acid treatment of gram positive bacteria containing peptidoglycan, removing insolubles, neutralizing and lyophil-izing
12/02/2004	WO2004104493A2 Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same
12/02/2004	WO2004104492A2 Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
12/02/2004	WO2004104491A2 Percussively ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
12/02/2004	WO2004104490A1 Self-contained heating unit and drug-supply unit employing same
12/02/2004	WO2004104204A1 RECOMBINANT GENE MEDICINE OF ADENOVIRUS VECTOR AND GENE p53 FOR TREATING PROLIFERATIVE DISEASES
12/02/2004	WO2004104188A1 Method for the in vitro production of cartilage-like tissue
12/02/2004	WO2004104185A1 Generation and isolation of antigen-specific t cells
12/02/2004	WO2004104183A2 Method for the in vitro production of cartilage-like tissue
12/02/2004	WO2004104182A1 Bioactive peptide-producing strains of enterococcus faecalis, bioactive peptides and applications thereof
12/02/2004	WO2004104159A1 Method and apparatus for mechanical stimulation of tissue in vitro
12/02/2004	WO2004103384A1 Pharmaceutical active agent containing a peptide toxin extracted from the venom of snakes in the genus crotalus
12/02/2004	WO2004103332A1 Cosmetic preparations
12/02/2004	WO2004103285A2 Lactoferrin in the treatment of diabetes mellitus
12/02/2004	WO2004103271A2 Disease prevention and vaccination prior to thymic reactivations
12/02/2004	WO2004103083A1 A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survival property, intestinal binding property, an infection protection property and a fiber fermenting property
12/02/2004	WO2004103073A1 Emu oil based methods and compositions
12/02/2004	WO2004090095A3 Generation of human regulatory t cells by bacterial toxins for the treatment of inflammatory disorders
12/02/2004	WO2004085628A8 Lactic acid utilising bacteria and their therapeutic use
12/02/2004	WO2004083364A3 Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof
12/02/2004	WO2004007665A3 Methods for inducing differentiation of embryonic stem cells and uses thereof
12/02/2004	WO2003089592A3 Enhancement of hematopoietic stem cell survival
12/02/2004	WO2002051981A3 Defects in periaxin associated with myelinopathies

1 ... 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 ... 1259